Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 6 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Arcus Biosciences Inc have a median target of 35.00, with a high estimate of 46.00 and a low estimate of 23.00. The median estimate represents a 108.33% increase from the last price of 16.80.
High | 173.8% | 46.00 |
Med | 108.3% | 35.00 |
Low | 36.9% | 23.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate | -462.48% |
Average growth rate | -13.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +75.46% |
Average growth rate | +186.11% |
More ▼